NO20053548L - Pulvermedikament for inhalering inneholdende et tiotropiumsalt og salmeterolxinafoat. - Google Patents

Pulvermedikament for inhalering inneholdende et tiotropiumsalt og salmeterolxinafoat.

Info

Publication number: NO20053548L
Authority: NO; Norway
Prior art keywords: powder; salmeterol xinafoate; tiotropium salt; inhalation containing; inhalation
Prior art date: 2002-12-20

Application number

NO20053548A

Other languages

English (en)

Norwegian (no)

Inventor

Rainer Soyka

Peter Sieger

Michael Walz

Michael Trunk

Hagen Grabner

Mareke Hartig-Heimel

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-20

Filing date

2005-07-19

Publication date

2005-09-02

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32404034&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20053548(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-07-19 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2005-09-02 Publication of NO20053548L publication Critical patent/NO20053548L/no

Links

GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 title abstract 2
229960005018 salmeterol xinafoate Drugs 0.000 title abstract 2
LERNTVKEWCAPOY-DZZGSBJMSA-N tiotropium Chemical class O([C@H]1C[C@@H]2[N+]([C@H](C1)[C@@H]1[C@H]2O1)(C)C)C(=O)C(O)(C=1SC=CC=1)C1=CC=CS1 LERNTVKEWCAPOY-DZZGSBJMSA-N 0.000 title abstract 2
239000000843 powder Substances 0.000 title 1
238000002360 preparation method Methods 0.000 abstract 3
208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 2
208000006673 asthma Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
208000023504 respiratory system disease Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Emergency Medicine (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Otolaryngology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20053548A 2002-12-20 2005-07-19 Pulvermedikament for inhalering inneholdende et tiotropiumsalt og salmeterolxinafoat. NO20053548L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10259912		2002-12-20
PCT/EP2003/013691 WO2004058233A1 (de)	2002-12-20	2003-12-04	Pulverförmige arzneimittel zur inhalation enthaltend ein tiotropiumsalz und salmeterolxinafoat

Publications (1)

Publication Number	Publication Date
NO20053548L true NO20053548L (no)	2005-09-02

Family

ID=32404034

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20053548A NO20053548L (no)	2002-12-20	2005-07-19	Pulvermedikament for inhalering inneholdende et tiotropiumsalt og salmeterolxinafoat.

Country Status (21)

Country	Link
EP (1)	EP1581198A1 (de)
JP (1)	JP2006516135A (de)
KR (1)	KR20050086930A (de)
CN (1)	CN1728988B (de)
AU (1)	AU2003288226B2 (de)
BR (1)	BR0317443A (de)
CA (1)	CA2510779A1 (de)
DE (1)	DE10351663A1 (de)
EA (1)	EA010588B1 (de)
EC (1)	ECSP055855A (de)
FR (1)	FR2848849B1 (de)
HR (1)	HRP20050570A2 (de)
IT (1)	ITMI20032473A1 (de)
MX (1)	MXPA05006519A (de)
NO (1)	NO20053548L (de)
NZ (1)	NZ541303A (de)
PL (1)	PL376231A1 (de)
RS (1)	RS20050484A (de)
UA (1)	UA83813C2 (de)
WO (1)	WO2004058233A1 (de)
ZA (1)	ZA200503692B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7407955B2 (en)	2002-08-21	2008-08-05	Boehringer Ingelheim Pharma Gmbh & Co., Kg	8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
DE102004054054A1 (de)	2004-11-05	2006-05-11	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
JP4342426B2 (ja) *	2004-11-24	2009-10-14	科研製薬株式会社	イトラコナゾール経口投与用製剤
WO2007017437A1 (en) *	2005-08-06	2007-02-15	Boehringer Ingelheim International Gmbh	Method for the treatment of dyspnea comprising combined administration of tiotropium salts and salts of salmeterol
US8163913B2 (en)	2005-12-19	2012-04-24	Sicor Inc.	Forms of tiotropium bromide and processes for preparation thereof
EP1852108A1 (de)	2006-05-04	2007-11-07	Boehringer Ingelheim Pharma GmbH & Co.KG	Zusammensetzungen von DPP-IV-Inhibitoren
EP2540725A1 (de)	2006-05-04	2013-01-02	Boehringer Ingelheim International GmbH	Polymorphe von 1-((4-Methyl-chinazolin-2-yl)methyl)-3-methyl-7-(2-butin-1-yl)-8-(3-(R)-amino-piperidin-1-yl)xanthin
PE20080251A1 (es)	2006-05-04	2008-04-25	Boehringer Ingelheim Int	Usos de inhibidores de dpp iv
DE102007036411A1 (de) *	2007-07-20	2009-02-12	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Pulverinhalator
PE20090907A1 (es) *	2007-07-21	2009-08-05	Boehringer Ingelheim Int	Nuevos medicamentos pulverulentos que contienen tiotropio y salmeterol, asi como lactosa como excipiente
PE20091730A1 (es)	2008-04-03	2009-12-10	Boehringer Ingelheim Int	Formulaciones que comprenden un inhibidor de dpp4
BRPI0916997A2 (pt)	2008-08-06	2020-12-15	Boehringer Ingelheim International Gmbh	Inibidor de dpp-4 e seu uso
UY32030A (es)	2008-08-06	2010-03-26	Boehringer Ingelheim Int	"tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
US20200155558A1 (en)	2018-11-20	2020-05-21	Boehringer Ingelheim International Gmbh	Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
CN102256976A (zh)	2008-12-23	2011-11-23	贝林格尔.英格海姆国际有限公司	有机化合物的盐形式
AR074990A1 (es)	2009-01-07	2011-03-02	Boehringer Ingelheim Int	Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
KR20240090632A (ko)	2009-11-27	2024-06-21	베링거 인겔하임 인터내셔날 게엠베하	리나글립틴과 같은 ｄｐｐ－ｉｖ 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료
CN102946875A (zh)	2010-05-05	2013-02-27	贝林格尔.英格海姆国际有限公司	组合疗法
WO2011161161A1 (en)	2010-06-24	2011-12-29	Boehringer Ingelheim International Gmbh	Diabetes therapy
AR083878A1 (es)	2010-11-15	2013-03-27	Boehringer Ingelheim Int	Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
US8883800B2 (en)	2011-07-15	2014-11-11	Boehringer Ingelheim International Gmbh	Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
US9555001B2 (en)	2012-03-07	2017-01-31	Boehringer Ingelheim International Gmbh	Pharmaceutical composition and uses thereof
JP6218811B2 (ja)	2012-05-14	2017-10-25	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Ｓｉｒｓ及び／又は敗血症の治療に用いるｄｐｐ−４阻害薬としてのキサンチン誘導体
JP6224084B2 (ja)	2012-05-14	2017-11-01	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	糸球体上皮細胞関連障害及び／又はネフローゼ症候群の治療に用いるｄｐｐ−４阻害薬としてのキサンチン誘導体
WO2013174767A1 (en)	2012-05-24	2013-11-28	Boehringer Ingelheim International Gmbh	A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
EP3110449B1 (de)	2014-02-28	2023-06-28	Boehringer Ingelheim International GmbH	Medizinische verwendung eines dpp-4-inhibitors
KR101748796B1 (ko) *	2015-09-30	2017-06-19	한미약품 주식회사	활성성분의 전달량이 향상된 흡입용 캡슐제
CN109310697A (zh)	2016-06-10	2019-02-05	勃林格殷格翰国际有限公司	利格列汀和二甲双胍的组合
BR112021009254A2 (pt) *	2018-11-13	2021-08-10	Cocrystal Pharma, Inc.	formulações para produtos terapêuticos para influenza

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1993016031A1 (en) *	1992-02-11	1993-08-19	Glaxo Group Limited	Benzenedimethanol derivative suitable for micronisation
CN1056974C (zh) *	1992-02-11	2000-10-04	格拉克索公司	适宜于微粒化的药物材料的制备方法
GB9313650D0 (en) *	1993-07-01	1993-08-18	Glaxo Group Ltd	Method and apparatus for the formation of particles
DE19921693A1 (de) *	1999-05-12	2000-11-16	Boehringer Ingelheim Pharma	Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
UA75375C2 (en) *	2000-10-12	2006-04-17	Boehringer Ingelheim Pharma	Method for producing powdery preparations for inhaling
DE10056104A1 (de) *	2000-11-13	2002-05-23	Boehringer Ingelheim Pharma	Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols
DE10104367A1 (de) *	2001-02-01	2002-08-08	Boehringer Ingelheim Pharma	Betamimetika enthaltende Arzneimittelkompositionen mit geringeren Nebenwirkungen
DE10130371A1 (de) *	2001-06-23	2003-01-02	Boehringer Ingelheim Pharma	Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
EP1416990A1 (de) *	2001-08-09	2004-05-12	Glaxo Group Limited	Inhalator mit einer pharmazeutischen zusammensetzung
JP2005504076A (ja) *	2001-09-14	2005-02-10	ベーリンガーインゲルハイムファルマゲゼルシャフトミットベシュレンクテルハフツングウントコンパニーコマンディトゲゼルシャフト	新規な吸入用医薬組成物

2003
- 2003-04-12 UA UAA200507088A patent/UA83813C2/ru unknown
- 2003-11-05 DE DE10351663A patent/DE10351663A1/de not_active Withdrawn
- 2003-12-04 RS YUP-2005/0484A patent/RS20050484A/sr unknown
- 2003-12-04 CN CN2003801069216A patent/CN1728988B/zh not_active Expired - Fee Related
- 2003-12-04 KR KR1020057011668A patent/KR20050086930A/ko not_active Ceased
- 2003-12-04 BR BR0317443-3A patent/BR0317443A/pt not_active IP Right Cessation
- 2003-12-04 HR HR20050570A patent/HRP20050570A2/xx not_active Application Discontinuation
- 2003-12-04 WO PCT/EP2003/013691 patent/WO2004058233A1/de not_active Ceased
- 2003-12-04 JP JP2004562686A patent/JP2006516135A/ja active Pending
- 2003-12-04 PL PL03376231A patent/PL376231A1/xx not_active Application Discontinuation
- 2003-12-04 EA EA200500902A patent/EA010588B1/ru not_active IP Right Cessation
- 2003-12-04 NZ NZ541303A patent/NZ541303A/en unknown
- 2003-12-04 EP EP03780120A patent/EP1581198A1/de not_active Withdrawn
- 2003-12-04 CA CA002510779A patent/CA2510779A1/en not_active Abandoned
- 2003-12-04 AU AU2003288226A patent/AU2003288226B2/en not_active Ceased
- 2003-12-04 MX MXPA05006519A patent/MXPA05006519A/es unknown
- 2003-12-16 IT IT002473A patent/ITMI20032473A1/it unknown
- 2003-12-19 FR FR0315082A patent/FR2848849B1/fr not_active Expired - Fee Related
2005
- 2005-05-09 ZA ZA200503692A patent/ZA200503692B/en unknown
- 2005-06-15 EC EC2005005855A patent/ECSP055855A/es unknown
- 2005-07-19 NO NO20053548A patent/NO20053548L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU2003288226A1 (en)	2004-07-22
AU2003288226B2 (en)	2010-01-07
KR20050086930A (ko)	2005-08-30
CN1728988A (zh)	2006-02-01
ECSP055855A (es)	2005-11-22
PL376231A1 (en)	2005-12-27
CA2510779A1 (en)	2004-07-15
BR0317443A (pt)	2005-11-16
ITMI20032473A1 (it)	2004-06-21
UA83813C2 (ru)	2008-08-26
HRP20050570A2 (en)	2006-07-31
MXPA05006519A (es)	2005-08-26
EP1581198A1 (de)	2005-10-05
EA010588B1 (ru)	2008-10-30
NZ541303A (en)	2008-11-28
WO2004058233A1 (de)	2004-07-15
JP2006516135A (ja)	2006-06-22
CN1728988B (zh)	2010-04-28
DE10351663A1 (de)	2004-07-01
EA200500902A1 (ru)	2006-02-24
ZA200503692B (en)	2006-10-25
FR2848849A1 (fr)	2004-06-25
RS20050484A (sr)	2007-11-15
FR2848849B1 (fr)	2007-01-05

Legal Events

Date	Code	Title	Description
2011-07-25	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20053548L (no)	2005-09-02	Pulvermedikament for inhalering inneholdende et tiotropiumsalt og salmeterolxinafoat.
MY123544A (en)	2006-05-31	New inhalable powder containing tiotropium
MY155912A (en)	2015-12-15	New inhalable powder containing tiotropium
MY143517A (en)	2011-05-31	Formoterol superfine formulation
CY1114157T1 (el)	2016-08-31	Αλατα του τιοτροπιου, μεθοδος για την παραγωγη τους και φαρμακευτικα σκευασματα που τα περιεχουν
CY1108420T1 (el)	2014-04-09	Προτοτυπο τιοτροπιουχο κονιωδες σκευασμα για εισπνοη
MY146628A (en)	2012-09-14	Novel crystalline anhydride with anticholinergic effect
NO20061441L (no)	2006-07-12	Nye tiotropiumsalter, metoder for deres fremstilling, og farmasoytiske formuleringer inneholdende disse
NO20051956L (no)	2005-07-22	Salmeterol superfin formulering
NO20073909L (no)	2007-10-24	Forstover-formulering
ATE339951T1 (de)	2006-10-15	Pulverzubereitungen zur inhalation
WO2005007134A8 (de)	2006-06-15	Pulverformulierungen für die inhalation enthaltend ein neues anticholinergikum
TH73286A (th)	2005-12-08	เกลือไทโอโทรเปียมใหม่ กรรมวิธีเพื่อการเตรียม และสารผสมยาของสารนั้น